Enter inventor name

Albuquerque, NM, United States of America

Eleanor L Schuler

This inventor holds 31 USPTO granted patents and 7 published patent applications, primarily in Bioelectronic Medical Technologies. Top assignees: Science Medicus, Inc., Neuro Code Tech Holdings, LLC, Codes of Life, LLC. Active years: 1996-2024.

USPTO Granted Patents = 31 (Patent Applications = 7)

% Patents Active = 58.1

Average Co-Inventor Count = 1.6

ph-index = 13

Forward Citations = 1,161(Granted Patents)

Location History:

Rio Rancho, MN (US) (2016)
Rio Rancho, NM (US) (1996 - 2021)
Albuquerque, NM (US) (2013 - 2024)

Company Filing History:

10 out of 10

Science Medicus, Inc.

patents

8 out of 8

Neuro Code Tech Holdings, LLC

Electroceuticals, LLC

patents

5. 1 out of 1

Neuro Code Teen Holdings; LLC

7. 6 out of 834,411

Other

patents

Years Active: 1996-2024

Loading Chart...

Areas of Expertise:

Bioelectronic Therapies

Cancer Treatment

Neuro-Electrical Signals

Cellular Apoptosis

Endocrine Regulation

Skeletal Muscle Control

Gastrointestinal Stimulation

Organ Modulation

Cardiac Control

Respiratory Management

Electrical Waveforms

Metal Particle Deposition

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11950923 - Systems, methods and apparatuses for providing bioelectronic neurocode-based therapies to mammals (2024-04-09),

2. 11154238 - Systems, methods and apparatuses for providing bioelectronic neurocode-based therapies to mammals (2021-10-26),

3. 9707403 - Rapid destruction of malignant tumors by excitotoxicity and osmotic-shock medical tactics (2017-07-18),

4. 9636507 - Rapid destruction of malignant tumors by excitotoxicity and osmotic-shock medical tactics (2017-05-02),

5. 9492478 - Encoded bioelectronic method and system and calcium treatment for slaying cancer by rapid triggering of cellular apoptosis and karyorrhexis (2016-11-15),

6. 9440083 - Rapid destruction of malignant tumors by excitotoxicity and osmotic-shock medical tactics (2016-09-13),

7. 9295835 - Encoded bioelectronic method and system and calcium treatment for slaying cancer by rapid triggering of cellular apoptosis and karyorrhexis (2016-03-29),

8. 9254388 - Method and system for regulation of endocrine and exocrine glands by means of neuro-electrical coded signals (2016-02-09),

9. 9032964 - Method and system for processing cancer cell electrical signals for medical therapy (2015-05-19),

10. 8831738 - System and method to elicit apoptosis in malignant tumor cells for medical treatment (2014-09-09),

11. 8818502 - Method and system for regulation of endocrine and exocrine glands by means of neuro-electrical coded signals (2014-08-26),

12. 8781593 - System and method for controlling skeletal muscles by means of neuro-electrical coded signals (2014-07-15),

13. 8725246 - Method and system for modulating eating behavior by means of neuro-electrical coded signals (2014-05-13),

14. 8656930 - Method and system for processing cancer cell electrical signals for medical therapy (2014-02-25),

15. 8509887 - Method to record, store and broadcast specific brain waveforms to modulate body organ functioning (2013-08-13),

Title: Innovation in Bioelectronic Therapies: The Contributions of Eleanor L. Schuler

Introduction

Eleanor L. Schuler, based in Albuquerque, NM, is a prominent inventor with an impressive portfolio of 31 patents. Her work primarily revolves around the development of advanced bioelectronic therapies for mammals, showcasing her commitment to innovating in the medical technology field.

Latest Patents

One of Schuler's latest patents focuses on "Systems, methods and apparatuses for providing bioelectronic neurocode-based therapies to mammals." This invention involves monitoring mammal conditions, reporting condition changes, and providing neurocode-based treatment accordingly. The patent details an implantable controller that can monitor health conditions, wirelessly communicate with external devices, and administer treatments based on the analysis performed by a remote computer. Such external devices may include mobile devices like smartphones or tablets, as well as specialized treatment pods and servers. The system can change biological functions or even trigger cell death in cancer cells, demonstrating its potential for significant medical impact.

Career Highlights

Eleanor has made noteworthy advances in her career, specifically through her roles at firms like Science Medicus, Inc. and Neuro Code Tech Holdings, LLC. Her work at these organizations has enabled her to merge her inventive spirit with practical applications, enhancing the realm of bioelectronic therapies.

Collaborations

Throughout her career, Eleanor has worked alongside esteemed colleagues such as Claude K. Lee and James K. Poliner. These collaborations have undoubtedly contributed to a dynamic exchange of ideas and innovations in the specialties they pursue.

Conclusion

Eleanor L. Schuler exemplifies the innovative spirit within the field of bioelectronic therapies. Her dedication to advancing medical technology through her extensive patent portfolio showcases the potential of innovations in improving health outcomes for mammals. Her continued work in this domain is expected to drive further advancements in medical science and technology.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]